Skip to main content
Erschienen in: Annals of Surgical Oncology 9/2008

01.09.2008 | Healthcare Policy and Outcomes

The Role of Health-Related Quality of Life Outcomes in Clinical Decision Making in Surgery for Esophageal Cancer: A Systematic Review

verfasst von: R. Parameswaran, MRCS, A. McNair, MRCS, K. N. L. Avery, PhD, R. G. Berrisford, FRCS (Th), S. A. Wajed, MCRir, FRCS, M. A. G. Sprangers, PhD, J. M. Blazeby, MD, FRCS

Erschienen in: Annals of Surgical Oncology | Ausgabe 9/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

Esophagectomy for cancer offers a chance of cure but is associated with morbidity, at least a temporary reduction in health-related quality of life (HRQL), and a 5-year survival of approximately 30%. This research evaluated how and whether HRQL outcomes contribute to surgical decision making.

Methods

A systematic review identified randomized trials and longitudinal and cross-sectional studies that assessed HRQL after esophagectomy with multidimensional validated questionnaires. Articles were independently evaluated by two reviewers, and the value of HRQL in clinical decision making was categorized in three ways: (1) the assessment of the quality of HRQL methodology according to predefined criteria; (2) the influence of HRQL outcomes on treatment recommendations and/or informed consent; and (3) the HRQL after esophagectomy for cancer in methodologically robust studies.

Results

Eighteen publications were identified, of which 16 (89%) were categorized as having robust HRQL design. Of these studies, 3 concluded that HRQL influenced treatment recommendations and 11 (including the former 3) informed patient consent. The remaining five papers were well designed, but the authors did not use HRQL to influence treatment recommendations or informed consent. After esophagectomy, patients report major deterioration in most aspects of HRQL with slow recovery.

Conclusion

HRQL outcomes are relevant to surgical decision making. Methods to communicate HRQL outcomes to patients are required to inform consent and clinical practice.
Literatur
1.
Zurück zum Zitat Hulscher JB, van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002; 347:1662–9.PubMedCrossRef Hulscher JB, van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002; 347:1662–9.PubMedCrossRef
2.
Zurück zum Zitat Jamieson GG, Mathew G, Ludemann R, et al. Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg 2004; 91:943–7.PubMedCrossRef Jamieson GG, Mathew G, Ludemann R, et al. Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg 2004; 91:943–7.PubMedCrossRef
3.
Zurück zum Zitat Portale G, Hagen JA, Peters JH, et al. Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients. J Am Coll Surg 2006; 202:588–96.PubMedCrossRef Portale G, Hagen JA, Peters JH, et al. Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients. J Am Coll Surg 2006; 202:588–96.PubMedCrossRef
4.
Zurück zum Zitat Altorki N, Skinner D. Should en bloc esophagectomy be the standard of care for esophageal carcinoma? Ann Surg 2001; 234:581–7.PubMedCrossRef Altorki N, Skinner D. Should en bloc esophagectomy be the standard of care for esophageal carcinoma? Ann Surg 2001; 234:581–7.PubMedCrossRef
5.
Zurück zum Zitat Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemothearpy in oesophageal cancer. Lancet 2002; 359:1727–33.CrossRef Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemothearpy in oesophageal cancer. Lancet 2002; 359:1727–33.CrossRef
6.
Zurück zum Zitat US Food and Drug Administration. Guidance for industry. Patient-reported outcome measures: use in medical product development for labeling claims. Rockville, MD: US Food and Drug Administration; 2006. p. 1–32. US Food and Drug Administration. Guidance for industry. Patient-reported outcome measures: use in medical product development for labeling claims. Rockville, MD: US Food and Drug Administration; 2006. p. 1–32.
7.
Zurück zum Zitat Stahl M, Stuschke M, Lehmann N, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005; 23:2310–7.PubMedCrossRef Stahl M, Stuschke M, Lehmann N, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005; 23:2310–7.PubMedCrossRef
8.
Zurück zum Zitat Urba SG, Orringer MB, Turrisi A, et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001; 19:305–13.PubMed Urba SG, Orringer MB, Turrisi A, et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001; 19:305–13.PubMed
9.
Zurück zum Zitat Goodwin PJ, Black JT, Bordeleau LJ, et al. Health-related quality-of-life measurement in randomized clinical trials in breast cancer—taking stock. J Natl Cancer Inst 2003; 95:263–81.PubMedCrossRef Goodwin PJ, Black JT, Bordeleau LJ, et al. Health-related quality-of-life measurement in randomized clinical trials in breast cancer—taking stock. J Natl Cancer Inst 2003; 95:263–81.PubMedCrossRef
10.
Zurück zum Zitat Efficace F, Bottomley A, Osoba D, et al. Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials—does HRQOL evaluation in prostate cancer research inform clinical decision making? J Clin Oncol 2003; 21:3502–11.PubMedCrossRef Efficace F, Bottomley A, Osoba D, et al. Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials—does HRQOL evaluation in prostate cancer research inform clinical decision making? J Clin Oncol 2003; 21:3502–11.PubMedCrossRef
11.
Zurück zum Zitat Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30:473–83.PubMedCrossRef Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30:473–83.PubMedCrossRef
12.
Zurück zum Zitat Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85:365–76.PubMedCrossRef Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85:365–76.PubMedCrossRef
13.
Zurück zum Zitat de Haes JCJM, Olschewski M, Fayers PM, et al. Measuring the quality of life of cancer patients: the Rotterdam symptom checklist (RSCL): a manual. Groningen, The Netherlands: Northern Centre for Healthcare Research, 1996 de Haes JCJM, Olschewski M, Fayers PM, et al. Measuring the quality of life of cancer patients: the Rotterdam symptom checklist (RSCL): a manual. Groningen, The Netherlands: Northern Centre for Healthcare Research, 1996
14.
Zurück zum Zitat Luketich JD, Velo-Rivera M, Buenaventura PO, et al. Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg 2003; 238:486–94.PubMed Luketich JD, Velo-Rivera M, Buenaventura PO, et al. Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg 2003; 238:486–94.PubMed
15.
Zurück zum Zitat O’Hanlon DM, Harkin M, Karat D, et al. Quality-of-life assessment in patients undergoing treatment for oesophageal carcinoma. Br J Surg 1995; 82:1682–5.PubMedCrossRef O’Hanlon DM, Harkin M, Karat D, et al. Quality-of-life assessment in patients undergoing treatment for oesophageal carcinoma. Br J Surg 1995; 82:1682–5.PubMedCrossRef
16.
Zurück zum Zitat Zieren HU, Jacobi CA, Zieren J, et al. Quality of life following resection of oesophageal carcinoma. Br J Surg 1996; 83:1772–5.PubMedCrossRef Zieren HU, Jacobi CA, Zieren J, et al. Quality of life following resection of oesophageal carcinoma. Br J Surg 1996; 83:1772–5.PubMedCrossRef
17.
Zurück zum Zitat Blazeby JM, Farndon JR, Donovan J, et al. A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer 2000; 88:1781–7.PubMedCrossRef Blazeby JM, Farndon JR, Donovan J, et al. A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer 2000; 88:1781–7.PubMedCrossRef
18.
Zurück zum Zitat Brooks JA, Kesler KA, Johnson CS, et al. Prospective analysis of quality of life after surgical resection for esophageal cancer: preliminary results. J Surg Oncol 2002; 81:185–94.PubMedCrossRef Brooks JA, Kesler KA, Johnson CS, et al. Prospective analysis of quality of life after surgical resection for esophageal cancer: preliminary results. J Surg Oncol 2002; 81:185–94.PubMedCrossRef
19.
Zurück zum Zitat de Boer AG, van Lanschot JJ, van Sandick JW, et al. Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. J Clin Oncol 2004; 22:4202–8.PubMedCrossRef de Boer AG, van Lanschot JJ, van Sandick JW, et al. Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. J Clin Oncol 2004; 22:4202–8.PubMedCrossRef
20.
Zurück zum Zitat Blazeby JM, Sanford E, Falk SJ, et al. Health-related quality of life during neoadjuvant treatment and surgery for localized esophageal carcinoma. Cancer 2005; 103:1791–9.PubMedCrossRef Blazeby JM, Sanford E, Falk SJ, et al. Health-related quality of life during neoadjuvant treatment and surgery for localized esophageal carcinoma. Cancer 2005; 103:1791–9.PubMedCrossRef
21.
Zurück zum Zitat Bonnetain F, Bouche O, Michel P, et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Ann Oncol 2006; 17:827–34.PubMedCrossRef Bonnetain F, Bouche O, Michel P, et al. A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer. Ann Oncol 2006; 17:827–34.PubMedCrossRef
22.
Zurück zum Zitat Cense HA, Hulscher JB, de Boer AG, et al. Effects of prolonged intensive care unit stay on quality of life and long-term survival after transthoracic esophageal resection. Crit Care Med 2006; 34:354–62.PubMedCrossRef Cense HA, Hulscher JB, de Boer AG, et al. Effects of prolonged intensive care unit stay on quality of life and long-term survival after transthoracic esophageal resection. Crit Care Med 2006; 34:354–62.PubMedCrossRef
23.
Zurück zum Zitat Reynolds JV, McLaughlin R, Moore J, et al. Prospective evaluation of quality of life in patients with localized oesophageal cancer treated by multimodality therapy or surgery alone. Br J Surg 2006; 93:1084–90.PubMedCrossRef Reynolds JV, McLaughlin R, Moore J, et al. Prospective evaluation of quality of life in patients with localized oesophageal cancer treated by multimodality therapy or surgery alone. Br J Surg 2006; 93:1084–90.PubMedCrossRef
24.
Zurück zum Zitat van Knippenberg FC, Out JJ, Tilanus HW, et al. Quality of Life in patients with resected oesophageal cancer. Soc Sci Med 1992; 35:139–45.PubMedCrossRef van Knippenberg FC, Out JJ, Tilanus HW, et al. Quality of Life in patients with resected oesophageal cancer. Soc Sci Med 1992; 35:139–45.PubMedCrossRef
25.
Zurück zum Zitat McLarty AJ, Deschamps C, Trastek VF, et al. Esophageal resection for cancer of the esophagus: long-term function and quality of life. Ann Thorac Surg 1997; 63:1568–72.PubMedCrossRef McLarty AJ, Deschamps C, Trastek VF, et al. Esophageal resection for cancer of the esophagus: long-term function and quality of life. Ann Thorac Surg 1997; 63:1568–72.PubMedCrossRef
26.
Zurück zum Zitat Hallas CN, Patel N, Oo A, et al. Five-year survival following oesophageal cancer resection: psychosocial functioning and quality of life. Psychol Health Med 2001; 6:84–94.CrossRef Hallas CN, Patel N, Oo A, et al. Five-year survival following oesophageal cancer resection: psychosocial functioning and quality of life. Psychol Health Med 2001; 6:84–94.CrossRef
27.
Zurück zum Zitat Headrick JR, Nichols FC III, Miller DL, et al. High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy. Ann Thorac Surg 2002; 73:1697–702.PubMedCrossRef Headrick JR, Nichols FC III, Miller DL, et al. High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy. Ann Thorac Surg 2002; 73:1697–702.PubMedCrossRef
28.
Zurück zum Zitat Schmidt CE, Bestmann B, Kuchler T, et al. Quality of life associated with surgery for esophageal cancer: differences between collar and intrathoracic anastomoses. World J Surg 2004; 28:355–60.PubMedCrossRef Schmidt CE, Bestmann B, Kuchler T, et al. Quality of life associated with surgery for esophageal cancer: differences between collar and intrathoracic anastomoses. World J Surg 2004; 28:355–60.PubMedCrossRef
29.
Zurück zum Zitat Viklund P, Lindblad M, Lagergren J. Influence of surgery-related factors on quality of life after esophageal or cardia cancer resection. World J Surg 2005; 29:841–8.PubMedCrossRef Viklund P, Lindblad M, Lagergren J. Influence of surgery-related factors on quality of life after esophageal or cardia cancer resection. World J Surg 2005; 29:841–8.PubMedCrossRef
30.
Zurück zum Zitat Viklund P, Wengstrom Y, Rouvelas I, et al. Quality of life and persisting symptoms after oesophageal cancer surgery. Eur J Cancer 2006; 42:1407–14.PubMedCrossRef Viklund P, Wengstrom Y, Rouvelas I, et al. Quality of life and persisting symptoms after oesophageal cancer surgery. Eur J Cancer 2006; 42:1407–14.PubMedCrossRef
31.
Zurück zum Zitat Cense HA, Visser MR, van Sandick JW, et al. Quality of life after colon interposition by necessity for esophageal cancer replacement. J Surg Oncol 2004; 88:32–8.PubMedCrossRef Cense HA, Visser MR, van Sandick JW, et al. Quality of life after colon interposition by necessity for esophageal cancer replacement. J Surg Oncol 2004; 88:32–8.PubMedCrossRef
32.
Zurück zum Zitat Leibman S, Smithers BM, Gotley DC, et al. Minimally invasive esophagectomy: short- and long-term outcomes. Surg Endosc 2006; 20:428–33.PubMedCrossRef Leibman S, Smithers BM, Gotley DC, et al. Minimally invasive esophagectomy: short- and long-term outcomes. Surg Endosc 2006; 20:428–33.PubMedCrossRef
33.
Zurück zum Zitat de Boer AG, Genovesi PI, Sprangers MA, et al. Quality of life in long-term survivors after curative transhiatal oesophagectomy for oesophageal carcinoma. Br J Surg 2000; 87:1716–21.PubMedCrossRef de Boer AG, Genovesi PI, Sprangers MA, et al. Quality of life in long-term survivors after curative transhiatal oesophagectomy for oesophageal carcinoma. Br J Surg 2000; 87:1716–21.PubMedCrossRef
34.
Zurück zum Zitat Spector NM, Hicks FD, Pickleman J. Quality of life and symptoms after surgery for gastroesophageal cancer: a pilot study. Gastroenterol Nurs 2002; 25:120–5.PubMedCrossRef Spector NM, Hicks FD, Pickleman J. Quality of life and symptoms after surgery for gastroesophageal cancer: a pilot study. Gastroenterol Nurs 2002; 25:120–5.PubMedCrossRef
35.
Zurück zum Zitat Blazeby JM, Nicklin J, Brookes ST, et al. Feasibility of quality of life assessment in patients with upper gastrointestinal tract cancer. Br J Cancer 2003; 89:497–501.PubMedCrossRef Blazeby JM, Nicklin J, Brookes ST, et al. Feasibility of quality of life assessment in patients with upper gastrointestinal tract cancer. Br J Cancer 2003; 89:497–501.PubMedCrossRef
36.
Zurück zum Zitat Blazeby JM, Avery K, Sprangers M, et al. Health-related quality of life measurement in randomized clinical trials in surgical oncology. J Clin Oncol 2006; 24:3178–86.PubMedCrossRef Blazeby JM, Avery K, Sprangers M, et al. Health-related quality of life measurement in randomized clinical trials in surgical oncology. J Clin Oncol 2006; 24:3178–86.PubMedCrossRef
37.
Zurück zum Zitat Lagergren P, Avery KN, Hughes R, et al. Health-related quality of life among patients cured by surgery for esophageal cancer. Cancer 2007; 110:686–93.PubMedCrossRef Lagergren P, Avery KN, Hughes R, et al. Health-related quality of life among patients cured by surgery for esophageal cancer. Cancer 2007; 110:686–93.PubMedCrossRef
38.
Zurück zum Zitat Medical Defence Union. Consent to Treatment. London: MDU, 2004 Medical Defence Union. Consent to Treatment. London: MDU, 2004
39.
Zurück zum Zitat Gore DM. Ethical, professional, and legal obligations in clinical practice: a series of discussion topics for postgraduate medical education. Introduction and topic 1: informed consent. Postgrad Med J 2001; 77:238–9.PubMedCrossRef Gore DM. Ethical, professional, and legal obligations in clinical practice: a series of discussion topics for postgraduate medical education. Introduction and topic 1: informed consent. Postgrad Med J 2001; 77:238–9.PubMedCrossRef
41.
Zurück zum Zitat Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998; 16:139–44.PubMed Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998; 16:139–44.PubMed
42.
Zurück zum Zitat King MT. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 1996; 5:555–67.PubMedCrossRef King MT. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 1996; 5:555–67.PubMedCrossRef
43.
Zurück zum Zitat Gradauskas P, Rubikas R, Saferis V. Changes in quality of life after esophageal resections for carcinoma. Medicina (Kaunas) 2006; 42:187–94. Gradauskas P, Rubikas R, Saferis V. Changes in quality of life after esophageal resections for carcinoma. Medicina (Kaunas) 2006; 42:187–94.
Metadaten
Titel
The Role of Health-Related Quality of Life Outcomes in Clinical Decision Making in Surgery for Esophageal Cancer: A Systematic Review
verfasst von
R. Parameswaran, MRCS
A. McNair, MRCS
K. N. L. Avery, PhD
R. G. Berrisford, FRCS (Th)
S. A. Wajed, MCRir, FRCS
M. A. G. Sprangers, PhD
J. M. Blazeby, MD, FRCS
Publikationsdatum
01.09.2008
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 9/2008
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-008-0042-8

Weitere Artikel der Ausgabe 9/2008

Annals of Surgical Oncology 9/2008 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.